Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke

Deferoxamine (DFO) is a high-affinity iron chelator approved by the Food and Drug Administration for treating iron overload. Preclinical research suggests that systemically administered DFO prevents and treats ischemic stroke damage and intracerebral hemorrhage. However, translation into human trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hanson, Leah R., Roeytenberg, Annina, Martinez, Paula M., Coppes, Valerie G., Sweet, Donald C., Rao, Reshma J., Marti, Dianne L., Hoekman, John D., Matthews, Rachel B., Frey, William H., Panter, S. Scott
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Pharmacology and Experimental Therapeutics 2009
Assuntos:
Neuropharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729791/
https://ncbi.nlm.nih.gov/pubmed/19509317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.108.149807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados